Stock UniverseDerived research view · source repositories remain read-only

argenx SE (ARGX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Very High
Selection Score
51.66
Global Rank
38
Market Cap
47.54B
Latest Close
891.32
RS Composite
5.18% · G#999

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
10.37%
3M
24.17%
6M
-3.31%
1Y
55.42%
3Y
129.31%
5Y
219.48%
10Y
3775.30%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 794.47K · 30-day average: 328.99K · Max drawdown over stored range: -38.20%

Research Snapshot

Relative Strength vs SPX

RS Composite5.18%
20D RS12.58%
60D RS13.45%
120D RS-6.79%
Global RS Rank999 · 70.22% percentile
Qualified+ RS Rank372 · 70.43% percentile
Group ScopeQualified+
Primary RS Rank111 · 75.76% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank3 / 701
Primary Percentile99.71
Score Notesmarket-cap support, industry-tailwind, category-leader

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ARGX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue61.96528.266441.0111268.5942248.2054248.05
Revenue Growth (YoY)-33.241%752.592%-16.517%187.656%77.22%88.953%
Gross Profit-308.925-52.254-251.786291.2671037.4932433.253
Operating Income-480.568-359.898-723.918-420.638-17.8441066.196
Free Cash Flow-399.531-610.435-863.644-421.139-84.548679.027
Free Cash Flow Per Share-8.798-11.952-15.881-7.367-1.29710.284
EPS (Diluted) GAAP-13.39901-7.993311-13.05-5.16104312.7819.57
EPS Growth53.13%
EPS Non-GAAP
Gross Margin10100%-9.892%-57.093%22.96%46.148%57.279%
Operating Margin-775.61%-68.128%-164.15%-33.158%-0.794%25.098%
Profit Margin-982.013%-77.284%-160.902%-23.258%37.054%30.415%
Free Cash Flow Margin-644.821%-115.554%-195.833%-33.197%-3.761%15.984%
Shares Outstanding (Diluted)45.410451.075854.381457.169365.177866.0292
Shares Change (YoY)17.585%12.476%6.472%5.127%14.009%1.306%

SEC Quarterly Fundamentals

No processed quarterly rows for ARGX.